Janet Shipley

Dr Janet Shipley leads the Molecular Cytogenetics Team at The Institute of Cancer Research. She is investigating how faulty genes lead to the development of a type of childhood cancer called rhabdomyosarcoma. Some forms of this disease are very difficult to treat, so new approaches are urgently needed. Dr Shipley's research is revealing new targets for the development of drugs to improve the outcome for children with rhabdomyosarcoma.